NEVVI Medicare utilization intelligence

← back

SADEGHI, SAEEDMD NPI 1144240334 Clinician

Hematology-Oncology · SANTA MONICA, CA

Specialty Hematology-Oncology — from billed Medicare claims
Trained SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 27 years since medical school (class of 1999, self-reported to CMS)
Location SANTA MONICA, CA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 36 codes billed · 44,223 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2019–2026
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J0897 Injection, denosumab, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J1100 Injection, dexamethasone sodium phosphate, 1 mg
80053 Blood test, comprehensive group of blood chemicals
J2469 Injection, palonosetron hcl, 25 mcg
96372 Injection of drug or substance under skin or into muscle
82728 Ferritin (blood protein) level
J7050 Infusion, normal saline solution, 250 cc
96375 Injection of additional new drug or substance into vein
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
83615 Lactate dehydrogenase (enzyme) level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
36415 Insertion of needle into vein for collection of blood sample
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
83540 Iron level
82784 Gammaglobulin (immune system protein) measurement
96413 Administration of chemotherapy into vein, 1 hour or less
82232 Beta-2 microglobulin (protein) level
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
82607 Cyanocobalamin (vitamin b-12) level
J1200 Injection, diphenhydramine hcl, up to 50 mg
82378 Carcinoembryonic antigen (cea) protein level
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
83550 Iron binding capacity
85045 Red blood count, automated test
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
82746 Folic acid level, serum
99443 Telephone medical discussion with physician, 21-30 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.